compounded glp 1 injections GLP-1 Hims Inc. - Hims &

GLP-1 drugs linked to lower risk for dementia in older adults with diabetes: Study A new study found that adults over the age of 60 and on a GLP-1 medication reduced their likelihood of developing dementia by 23 to 44%, depending which medication they were on

The anti-inflammatory properties of GLP-1 agonists additionally contribute to their cardiovascular benefits

Retatrutide is Eli Lillys once weekly injectable that targets three pathways at the same time, GLP-1, GIP, and glucagon

Both the GLP-1R/GIP coagonist and the tri-agonist similarly reduced blood glucose levels and improved glucose tolerance without induction of hypoglycaemia, and this demonstrates that chronic GCGR agonism does not overpower the anti-hyperglycemic effects of GLP-1R and GIPR activation

The study emphasized the importance of weight loss in the management of hypertension, particularly in populations taking antihypertensive drugs